Chi-Jen Chang

Chi-Jen Chang

Auto-generated profile, based on publicly available information

Chi-Jen Chang

Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan (Y.-H.Y., Y.-S.K., Y.-H.C., C.-J.C., L.-A.H.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
CCChi‐Jen Chang
Chi‐Jen Chang
YTYing-Chang Tung
Ying-Chang Tung
JLJia‐Rou Liu
Jia‐Rou Liu
SCShu‐Hao Chang
Shu‐Hao Chang
CKChi‐Tai Kuo
Chi‐Tai Kuo
LSLai-Chu See
Lai-Chu See

1 June 2026 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
YYYung-Hsin Yeh
Yung-Hsin Yeh
YKYu-Shien Ko
Yu-Shien Ko
YCYi-Hsin Chan
Yi-Hsin Chan
YLYing-Ju Lai
Ying-Ju Lai
Gwo-Jyh ChangGwo-Jyh Chang
Gwo-Jyh Chang
LHLung-An Hsu
Lung-An Hsu
BACKGROUND: Arrhythmogenic cardiomyopathy is an inherited disorder characterized by fibro-fatty myocardial replacement and ventricular arrhythmias. Although desmosomal mutations such as desmoglein-2 ( DSG2 ) are well-established causes, the pathogenic mechanisms of specific missense variants remain incompletely defined. METHODS: We generated a physiologically relevant Dsg2 F536C/F536C knock-in mouse model using CRISPR/Cas9 to mimic the human DSG2 p.Phe531Cys mutation. Comprehensive phenotyping included histopathology, immunostaining, transcriptomic profiling, in vitro cardiomyocyte and fibroblast assays, in vivo imaging and ECG analysis, and ex vivo optical mapping. Therapeutic potential was assessed using the PPAR-γ (peroxisome proliferator-activated receptor gamma) antagonist GW9662. RESULTS: Dsg2 F536C/F536C mice developed progressive cardiac hypertrophy, interstitial fibrosis, lipid accumulation, and inducible ventricular arrhythmias following isoproterenol infusion and programmed electrical stimulation. These changes led to severe cardiac dysfunction and reduced survival. Mechanistically, the mutation caused reduced DSG2 and nuclear accumulation of β-catenin and PPAR-γ, promoting triacylglycerol biosynthesis, oxidative stress, cardiomyocyte death, and calcium-handling abnormalities. We also identified activation of epicardial epithelial-to-mesenchymal transition and paracrine fibroblast activation via IL-6 (interleukin-6) and PDGF-BB (platelet-derived growth factor-BB) as key contributors to fibrotic remodeling. Optical mapping revealed prolonged and heterogeneous action potential duration, with both reentrant and focal ectopic mechanisms of ventricular tachycardia. Treatment with GW9662 attenuated lipid accumulation, fibrosis, reactive oxygen species production, and arrhythmogenic susceptibility. CONCLUSIONS: The Dsg2 F536C/F536C knock-in mouse is a genotype-specific arrhythmogenic cardiomyopathy model that links desmosomal dysfunction to metabolic remodeling, epicardial epithelial-to-mesenchymal transition, and electrophysiological instability. PPAR-γ inhibition ameliorated structural and arrhythmogenic remodeling, supporting PPAR-γ as a potential therapeutic target and advancing precision strategies for desmosome-related cardiomyopathies.

17 March 2021 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
JPJian-Rong Peng
Jian-Rong Peng
HSHung-Chi Su
Hung-Chi Su
CLCHIA-PIN LIN
CHIA-PIN LIN
CCChun-Chi Chen
Chun-Chi Chen
CCChi-Jen Chang
Chi-Jen Chang
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
Background. The use of electronic health (e-health) resources is emerging as an alternative method to improve the secondary prevention of coronary artery disease (CAD). The aim of this study was to describe the influence of an e-health application in holistic healthcare for patients with CAD. Methods. A quasiexperiment with nonequivalent groups design recruited outpatients with a high risk of CAD admitted for cardiac catheterization. They were divided into two groups. Before the procedure, the control group received traditional patient education, and the intervention group watched videos on Internet-based social media. EQ-5D and FACIT–Sp-12 questionnaires were used as outcome measures of interest, and they were administered before and after the procedure and at the first return visit to the outpatient clinic after discharge. The effect of each intervention was tested using a linear mixed effects model. In addition, the 90-day readmission rate was also studied. Results. A total of 300 patients were divided into intervention and control groups (150 patients in each group). The interaction effect of EQ-5D was not statistically significant; however, improvements in FACIT–Sp-12 were greater in the intervention group from baseline to before discharge (regression coefficient (B) = 1.70, ) and from baseline to postdischarge first outpatient visit (B = 1.81, ). Moreover, the 90-day readmission rate was significantly lower in the intervention group (14% vs. 18.7%; , log-rank test). Conclusions. e-health intervention with easily accessible Internet-based social media is a promising model to meet the holistic needs of patients with CAD in the modern era.